Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Immunocore Holdings (IMCR) Total Non-Current Liabilities (2019 - 2025)

Immunocore Holdings (IMCR) has disclosed Total Non-Current Liabilities for 7 consecutive years, with $609.3 million as the latest value for Q3 2025.

  • Quarterly Total Non-Current Liabilities fell 13.42% to $609.3 million in Q3 2025 from the year-ago period, while the trailing twelve-month figure was $609.3 million through Sep 2025, down 13.42% year-over-year, with the annual reading at $648.8 million for FY2024, 185.58% up from the prior year.
  • Total Non-Current Liabilities hit $609.3 million in Q3 2025 for Immunocore Holdings, roughly flat from $609.9 million in the prior quarter.
  • In the past five years, Total Non-Current Liabilities ranged from a high of $703.8 million in Q3 2024 to a low of $86.4 million in Q4 2022.
  • Historically, Total Non-Current Liabilities has averaged $486.0 million across 5 years, with a median of $609.6 million in 2025.
  • Biggest five-year swings in Total Non-Current Liabilities: fell 18.84% in 2021 and later surged 185.58% in 2024.
  • Year by year, Total Non-Current Liabilities stood at $93.1 million in 2021, then decreased by 7.16% to $86.4 million in 2022, then soared by 162.9% to $227.2 million in 2023, then surged by 185.58% to $648.8 million in 2024, then dropped by 6.08% to $609.3 million in 2025.
  • Business Quant data shows Total Non-Current Liabilities for IMCR at $609.3 million in Q3 2025, $609.9 million in Q2 2025, and $587.1 million in Q1 2025.